1. Home
  2. JVA vs CTXR Comparison

JVA vs CTXR Comparison

Compare JVA & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.41

Market Cap

17.8M

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.59

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
CTXR
Founded
1971
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
18.9M
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
JVA
CTXR
Price
$3.41
$0.59
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
89.7K
239.6K
Earning Date
06-12-2026
05-12-2026
Dividend Yield
1.71%
N/A
EPS Growth
N/A
43.38
EPS
0.33
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
$10.36
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$0.48
52 Week High
$5.62
$2.24

Technical Indicators

Market Signals
Indicator
JVA
CTXR
Relative Strength Index (RSI) 33.41 47.28
Support Level $3.28 $0.55
Resistance Level $3.92 $0.60
Average True Range (ATR) 0.15 0.04
MACD 0.00 0.01
Stochastic Oscillator 18.11 44.43

Price Performance

Historical Comparison
JVA
CTXR

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: